NCT05497284: An ongoing trial by Novartis Pharmaceuticals
This trial is ongoing. It must report results 1 day, 15 hours ago.
Full data
| Full entry on ClinicalTrials.gov | NCT05497284 |
|---|---|
| Title | A Participant- and Investigator-blinded, Randomized, Placebo-controlled, Multicenter, Platform Study to Investigate Efficacy, Safety, and Tolerability of Various Single Treatments in Participants With Idiopathic Pulmonary Fibrosis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 10, 2022 |
| Completion date | Aug. 26, 2024 |
| Required reporting date | Aug. 26, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Aug. 26, 2025 |
| Days late | None |